The Japan Times - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.301814
AFN 77.708293
ALL 96.176014
AMD 446.924892
ANG 2.097203
AOA 1074.135394
ARS 1698.74032
AUD 1.770078
AWG 2.108444
AZN 1.991912
BAM 1.950236
BBD 2.36247
BDT 143.341038
BGN 1.955079
BHD 0.441654
BIF 3477.877376
BMD 1.171358
BND 1.512285
BOB 8.104876
BRL 6.444114
BSD 1.172958
BTN 106.59388
BWP 15.491801
BYN 3.437408
BYR 22958.617481
BZD 2.359079
CAD 1.615232
CDF 2635.555553
CHF 0.933339
CLF 0.027334
CLP 1072.249192
CNY 8.248644
CNH 8.245095
COP 4499.162784
CRC 585.330013
CUC 1.171358
CUP 31.040988
CVE 109.951301
CZK 24.352124
DJF 208.874957
DKK 7.471771
DOP 75.364979
DZD 151.627638
EGP 55.766478
ERN 17.570371
ETB 182.088389
FJD 2.670112
FKP 0.872551
GBP 0.87877
GEL 3.15685
GGP 0.872551
GHS 13.489513
GIP 0.872551
GMD 86.100851
GNF 10199.898985
GTQ 8.982373
GYD 245.399857
HKD 9.112316
HNL 30.903829
HRK 7.536638
HTG 153.611735
HUF 387.432543
IDR 19557.696563
ILS 3.773032
IMP 0.872551
INR 105.882157
IQD 1536.622469
IRR 49340.51376
ISK 148.001104
JEP 0.872551
JMD 188.262873
JOD 0.830488
JPY 182.223503
KES 151.004694
KGS 102.43541
KHR 4696.600275
KMF 491.969805
KPW 1054.235599
KRW 1732.367947
KWD 0.359502
KYD 0.977515
KZT 604.617565
LAK 25412.604561
LBP 105039.563247
LKR 363.105585
LRD 207.617653
LSL 19.697785
LTL 3.458716
LVL 0.708543
LYD 6.354896
MAD 10.733975
MDL 19.752728
MGA 5298.881924
MKD 61.532571
MMK 2460.108883
MNT 4156.475757
MOP 9.398924
MRU 46.520274
MUR 53.941062
MVR 18.050801
MWK 2033.897151
MXN 21.056371
MYR 4.7891
MZN 74.861814
NAD 19.697785
NGN 1705.356781
NIO 43.166842
NOK 11.969757
NPR 170.550408
NZD 2.028622
OMR 0.450384
PAB 1.172953
PEN 3.951227
PGK 4.986772
PHP 68.718886
PKR 328.725128
PLN 4.214535
PYG 7878.555568
QAR 4.276698
RON 5.092357
RSD 117.397841
RUB 94.202038
RWF 1707.82745
SAR 4.39328
SBD 9.562266
SCR 15.804605
SDG 704.56838
SEK 10.937063
SGD 1.513547
SHP 0.878822
SLE 27.872113
SLL 24562.796602
SOS 670.387339
SRD 45.305812
STD 24244.746356
STN 24.430299
SVC 10.263761
SYP 12951.888916
SZL 19.680933
THB 36.933012
TJS 10.779545
TMT 4.111467
TND 3.425327
TOP 2.820349
TRY 50.041619
TTD 7.957331
TWD 36.794115
TZS 2900.810779
UAH 49.466868
UGX 4176.08534
USD 1.171358
UYU 45.889075
UZS 14222.422448
VES 320.06667
VND 30847.713845
VUV 142.118205
WST 3.269295
XAF 654.090834
XAG 0.017758
XAU 0.000271
XCD 3.165653
XCG 2.113978
XDR 0.813479
XOF 654.093618
XPF 119.331742
YER 279.193074
ZAR 19.608123
ZMK 10543.631377
ZMW 26.949227
ZWL 377.176809
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    0.4100

    82.01

    +0.5%

  • BCC

    0.5100

    75.84

    +0.67%

  • CMSD

    0.0150

    23.38

    +0.06%

  • CMSC

    0.0400

    23.34

    +0.17%

  • RIO

    0.1700

    75.99

    +0.22%

  • GSK

    -0.4600

    48.78

    -0.94%

  • BCE

    -0.2800

    23.33

    -1.2%

  • AZN

    -0.2100

    91.35

    -0.23%

  • BTI

    -0.4500

    57.29

    -0.79%

  • NGG

    -0.2600

    75.77

    -0.34%

  • RELX

    -0.2600

    40.82

    -0.64%

  • JRI

    -0.0500

    13.51

    -0.37%

  • RYCEF

    -0.3100

    14.64

    -2.12%

  • VOD

    0.0000

    12.7

    0%

  • BP

    -1.4900

    33.76

    -4.41%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

K.Okada--JT